Influence of hyperhomocysteinemia on the cellular redox state - Impact on homocysteine-induced endothelial dysfunction

被引:87
作者
Weiss, N
Heydrick, SJ
Postea, O
Keller, C
Keaney, JF
Loscalzo, J
机构
[1] Univ Munich, Klinikum Innenstadt, Med Poliklin, D-80336 Munich, Germany
[2] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
关键词
homocysteine; oxidant stress; nitric oxide; endothelial dysfunction;
D O I
10.1515/CCLM.2003.223
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Hyperhomocysteinemia is an independent risk factor for the development of atherosclerosis. An increasing body of evidence has implicated oxidative stress as being contributory to homocysteines deleterious effects on the vasculature. Elevated levels of homocysteine may lead to increased generation of superoxide by a biochemical mechanism involving nitric oxide synthase, and, to a lesser extent, by an increase in the chemical oxidation of homocysteine and other aminothiols in the circulation. The resultant increase in superoxide levels is further amplified by homocysteinedependent alterations in the function of cellular antioxidant enzymes such as cellular glutathione peroxidase or extracellular superoxide dismutase. One direct clinical consequence of elevated vascular superoxide levels is the inactivation of the vasorelaxant messenger nitric oxide, leading to endothelial dysfunction. Scavenging of superoxide anion by either superoxide dismutase or 4,5-dihydroxybenzene 1,3-disulfonate (Tiron) reverses endothelial dysfunction in hyperhomocysteinemic animal models and in isolated aortic rings incubated with homocysteine. Similarly, homocysteineinduced endothelial dysfunction is also reversed by increasing the concentration of the endogenous antioxidant glutathione or overexpressing cellular glutathione peroxidase in animal models of mild hyperhomocysteinemia. Taken together, these findings strongly suggest that the adverse vascular effects of homocysteine are at least partly mediated by oxidative inactivation of nitric oxide.
引用
收藏
页码:1455 / 1461
页数:7
相关论文
共 69 条
  • [1] HEPARIN-INDUCED RELEASE OF EXTRACELLULAR-SUPEROXIDE DISMUTASE FORM(V) TO PLASMA
    ADACHI, T
    YAMADA, H
    FUTENMA, A
    KATO, K
    HIRANO, K
    [J]. JOURNAL OF BIOCHEMISTRY, 1995, 117 (03) : 586 - 590
  • [2] ANDERSSON A, 1995, CLIN CHEM, V41, P361
  • [3] Flow-induced constriction in arterioles of hyperhomocysteinemic rats is due to impaired nitric oxide and enhanced thromboxane A2 mediation
    Bagi, Z
    Ungvari, Z
    Szollár, L
    Koller, A
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (02) : 233 - 237
  • [4] Bellamy MF, 1999, EUR J CLIN INVEST, V29, P659, DOI 10.1046/j.1365-2362.1999.00527.x
  • [5] Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults
    Bellamy, MF
    McDowell, IFW
    Ramsey, MW
    Brownlee, M
    Bones, C
    Newcombe, RG
    Lewis, MJ
    [J]. CIRCULATION, 1998, 98 (18) : 1848 - 1852
  • [6] Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial
    Boaz, M
    Smetana, S
    Weinstein, T
    Matas, Z
    Gafter, U
    Iaina, A
    Knecht, A
    Weissgarten, Y
    Brunner, D
    Fainaru, M
    Green, MS
    [J]. LANCET, 2000, 356 (9237) : 1213 - 1218
  • [7] Böger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173
  • [8] Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects
    Chambers, JC
    Obeid, OA
    Kooner, JS
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) : 2922 - 2927
  • [9] Investigation of relationship and protein-bound homocysteine between reduced, oxidized, and vascular endothelial function in healthy human subjects
    Chambers, JC
    Ueland, PM
    Wright, M
    Doré, CJ
    Refsum, H
    Kooner, JS
    [J]. CIRCULATION RESEARCH, 2001, 89 (02) : 187 - 192
  • [10] Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia - An effect reversible with vitamin C therapy
    Chambers, JC
    McGregor, A
    Jean-Marie, J
    Obeid, OA
    Kooner, JS
    [J]. CIRCULATION, 1999, 99 (09) : 1156 - 1160